As part of my PhD I develop lipid-based drug delivery systems focusing primarily on chronic diseases such as osteoarthritis. At University Hospital Zürich I developed an osteoarthritis primary cell model where I tested my formulations.

Co-founder and Strategic Leader of PharmaCamp - a platfrom for young talents to build business cases for biotech startups and big pharma; procured funding & managed budget. • Prepared a strategic roadmap for the project. • Recruited and led a team of 7 people. • Established professional relationships with numerous stakeholders from industry, academia & translational institutes and coordinated them. • Participated in marketing of "PharmaCamp 2022".

I developed a method for lyophilisation of cells for alogeneic cell therapy products through harnessing 3D culture system. Inventor of a patent (WO2021050896A1). I was also in charge of gathering data for modelling of the pilot-scale lyophilisation process to increase the efficiency of process development. I characterised one pilot size freeze-dryer and obtained experience in lyophilisation of biopharmaceuticals.